| Literature DB >> 34940959 |
Lauren E Skelly1, Celine Bailleul2, Jenna B Gillen3.
Abstract
Interval training is a form of exercise that involves intermittent bouts of relatively intense effort interspersed with periods of rest or lower-intensity exercise for recovery. Low-volume high-intensity interval training (HIIT) and sprint interval training (SIT) induce physiological and health-related adaptations comparable to traditional moderate-intensity continuous training (MICT) in healthy adults and those with chronic disease despite a lower time commitment. However, most studies within the field have been conducted in men, with a relatively limited number of studies conducted in women cohorts across the lifespan. This review summarizes our understanding of physiological responses to low-volume interval training in women, including those with overweight/obesity or type 2 diabetes, with a focus on cardiorespiratory fitness, glycemic control, and skeletal muscle mitochondrial content. We also describe emerging evidence demonstrating similarities and differences in the adaptive response between women and men. Collectively, HIIT and SIT have consistently been demonstrated to improve cardiorespiratory fitness in women, and most sex-based comparisons demonstrate similar improvements in men and women. However, research examining insulin sensitivity and skeletal muscle mitochondrial responses to HIIT and SIT in women is limited and conflicting, with some evidence of blunted improvements in women relative to men. There is a need for additional research that examines physiological adaptations to low-volume interval training in women across the lifespan, including studies that directly compare responses to MICT, evaluate potential mechanisms, and/or assess the influence of sex on the adaptive response. Future work in this area will strengthen the evidence-base for physical activity recommendations in women.Entities:
Keywords: Aerobic exercise; Cardiorespiratory fitness; Female; Glucose; Insulin resistance; Insulin sensitivity; Interval exercise; Mitochondria; Sex differences; Skeletal muscle
Year: 2021 PMID: 34940959 PMCID: PMC8702506 DOI: 10.1186/s40798-021-00390-y
Source DB: PubMed Journal: Sports Med Open ISSN: 2198-9761
Summary of adaptations related to cardiorespiratory fitness, insulin sensitivity, glycemic control, and mitochondrial content following common low-volume interval training protocols in women
| Protocol | Training duration | ||
|---|---|---|---|
| 2–4 weeks | 5–11 weeks | 12–16 weeks | |
| Repeated Wingate SIT (3–8 × 30 s) | ↑ | ↑ | ↑ |
↓ HbA1c [ ↔ HbA1c [ | ↔ HbA1c [ | ||
↑ CS protein content† [ ↔ CS maximal activity† [ ↔ COXIV protein content† [ | |||
HIIT (10–12 × 1 min) | ↑ ↔ | ↑ | ↑ |
↔ OGTT insulin sensitivity [ ↓ HOMA-IR [ | ↓ HOMA-IR [ | ||
↑ CS maximal activity [ ↑ COX activity [ | |||
Repeated sprint SIT (6–20 s efforts) | ↑ | ↑ | |
↓ HOMA-IR [ ↔ HOMA-IR [ ↓ HbA1c [ ↔ HbA1c [ | |||
Reduced-volume SIT (≤ 10 min session) | ↑ ↔ | ↑ | ↑ |
↔ OGTT insulin sensitivity [ ↔ 24 h glucose mean or AUC [ ↓ HOMA-IR† [ | ↔ HOMA-IR† [ | ||
↑ CS maximal activity† [ ↑ COXIV protein content† [ | |||
| Reduced-volume HIIT (5 × 1 min) | ↑ | ||
↔ OGTT glucose and insulin AUC [ ↓ HOMA-IR [ ↔ HbA1c [ | |||
↑ mitochondrial complex I, II, III, IV and V protein content† [ ↑ CS maximal activity† [ | |||
Studies were conducted in women who were classified as healthy [10, 46, 47, 49, 52, 54, 65, 69–72, 75, 79, 161], with overweight/obesity [44, 50, 51, 53, 55, 60–63, 66, 67, 73, 76, 100, 110, 121, 138, 162, 164, 167, 168] and/or type 2 diabetes [100, 162]. For transparency, the same cohort of women was examined in the following pairs of references: [50, 121] and [73, 138]. The symbol (†) denotes when a finding has only been documented in a study comparing responses between sexes and is based on a main effect of time for both men and women. Abbreviations: ↑ increase; ↓ decrease; ↔ no change; AUC area under the curve; COXIV cytochrome c oxidase subunit IV; CS citrate synthase; HbA1c glycated hemoglobin; HOMA-IR homeostatic model assessment of insulin resistance; OGTT oral glucose tolerance test; peak peak oxygen uptake
Sex-based comparisons of outcomes related to cardiorespiratory fitness, insulin sensitivity, glycemic control, and mitochondrial content following low-volume interval training
| References | Sample size (M/W) | Population | Intervention | Outcome | |||||
|---|---|---|---|---|---|---|---|---|---|
| Descriptives | Age (yr) | BMI (kg/m2) | Menstrual cycle phase; HC use | Interval training protocol | Duration (wk); frequency (sessions/wk); exercise mode | Sex-specific results | |||
| Astorino et al. [ | 11/9 | Rec active | M: ~ 25 W: ~ 25 | ~ 25 ~ 22 | ~ 46 ~ 41 | NR; NR | 4–6 × 30 s 'all out' sprints, 5 min recovery | 2–3 wks; 2–3 sessions/wk; cycling | ↑ |
| Bagley et al. [ | 24/17 | Healthy | M: ~ 38 W: ~ 41 | ~ 26 ~ 22 | ~ 43 ~ 34 | NR; NR | 4 × 20 s 'all out' sprints, 2 min recovery | 12 wks; 3 sessions/wk; cycling | ↑ ↔ FPG or FPI in M and W ↔ HOMA-IR in M and W |
| Bonafiglia et al. [ | 9/12 | Healthy, rec active | M: ~ 20 W: ~ 20 | ~ 25 ~ 23 | ~ 45 ~ 39 | NR; NR | 8 × 20 s at ~ 170% | 3 wks; 4 sessions/wk; cycling | ↑ |
| Bostad et al. [ | 6/9 | Healthy, untrained | M/W: ~ 21 | ~ 24 | ~ 37 | Uncontrolled; 4 participants using OC | 3 × 20 s ‘all out’ sprints, 2 min recovery | 12 wks; 3 sessions/wk; cycling | ↑ |
| Esbjörnsson Liljedahl et al. [ | 6/10 | Healthy, rec active | M: ~ 26 W: ~ 25 | ~ 23 ~ 22 | NR NR | NR; NR | 3 × 30 s 'all out' sprints, 20 min rest | 4 wks; 3 sessions/wk; cycling | ↔ CS maximal activity in M and W |
| Gillen et al. [ | 7/7 | Obese, inactive | M: ~ 29 W: ~ 30 | ~ 31 ~ 29 | ~ 31 ~ 28 | Uncontrolled; NR | 3 × 20 s 'all out' sprints, 2 min recovery | 6 wks; 3 sessions/wk; cycling | ↑ ↓ 24 h blood glucose mean and AUC in M and ↔ in W ( ↔ FPG in M and W ↓ FPI in M and W ↓ HOMA-IR in M and W ↑ CS maximal activity in M and W ↑ COXIV protein content in M and W |
| Metcalfe et al. [ | 7/8 | Healthy, inactive | M: ~ 26 W: ~ 24 | ~ 24 ~ 23 | ~ 36 ~ 33 | Trials separated by ~ 8 wks; NR | 2 × 20 s 'all out' sprints, ~ 3 min recovery | 6 wks; 3 sessions/wk; cycling | ↑ ↑ OGTT insulin sensitivity in M and ↔ in W |
| Metcalfe et al. [ | 17/18 | Healthy, inactive | M: ~ 33 W: ~ 36 | ~ 25 ~ 24 | ~ 39 ~ 32 | Trials separated by ~ 8 wks; NR | 2 × 20 s 'all out' sprints, ~ 3 min recovery | 6 wks; 3 sessions/wk; cycling | ↑ ↔ OGTT glucose or insulin AUC in M and W |
| Phillips et al. [ | 64/72 | Impaired glucose tolerance and/or BMI > 27, inactive | M/W: ~ 36 | ~ 32 | ~ 27 | NR; NR | 5 × 1 min at 125% | 6 wks; 3 sessions/wk; cycling | ↑ ↓ HOMA-IR in M and W |
| Scalzo et al. [ | 11/10 | Healthy, rec active | M: ~ 22 W: ~ 23 | ~ 22 ~ 23 | ~ 43 ~ 40 | Uncontrolled; 1 participant using OC | 4–8 × 30 s, 4 min recovery | 3 wks; 3 sessions/wk; cycling | ↑ > MPS in mitochondrial fraction in M versus W (trend > MPS in cluster of mitochondrial proteins in M versus W ( ↑ CS protein content in M and W ↔ COXIV protein content in M and W |
Søgaard et al. [ Chrøis et al. [ | 11/11 | Healthy, inactive | M: ~ 63 W: ~ 63 | ~ 31 ~ 31 | ~ 27 ~ 23 | NR; NR | 5 × 1 min at ~ 125% PPO, 1.5 min recovery | 6 wks; 3 sessions/wk; cycling | ↑ ↑ Clamp insulin sensitivity in M and W (M > W trend ↔ OGTT glucose or insulin AUC in M and W ↔ FPG or FPI in M and W ↓ HbA1c in M and ↔ in W ( ↑ CS maximal activity in M and W ↑ ETC protein content in M and W ↑ Mitochondrial respiratory capacity in M and ↔ in W ( |
| Weber et al. [ | 7/7 | Healthy, untrained | M: ~ 24 W: ~ 23 | ~ 26 ~ 23 | ~ 44 ~ 40 | Tested in follicular phase; NR | 3 × 2 min at ~ 100–120% of | 8 wks; 3 sessions/wk; cycling | ↑ ( |
Statistical significance for the sex by time interaction or independent t-test is presented for outcomes demonstrating a sex-based difference. Body mass index (BMI) was not reported in some studies [68, 69, 72, 74, 75, 163] and was estimated using the mean height and weight values reported. Abbreviations: > greater; ↑ increase; ↓ decrease; ↔ no change, AUC area under the curve; CGM continuous glucose monitor; COXIV cytochrome c oxidase subunit IV; CS citrate synthase; ETC electron transport chain; FPG fasting plasma glucose; FPI fasting plasma insulin; HbA1c glycated hemoglobin; HC hormonal contraceptive; HOMA-IR homeostatic model assessment of insulin resistance; M men; MPS muscle protein synthesis; NR not reported; OC oral contraceptive; OGTT oral glucose tolerance test; Rec active recreationally active; PPO peak power output; peak peak oxygen uptake; W women